1. Home
  2. SLDB vs CTRN Comparison

SLDB vs CTRN Comparison

Compare SLDB & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

N/A

Current Price

$6.17

Market Cap

623.0M

Sector

Health Care

ML Signal

N/A

Logo Citi Trends Inc.

CTRN

Citi Trends Inc.

N/A

Current Price

$47.94

Market Cap

559.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
SLDB
CTRN
Founded
2013
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
623.0M
559.1M
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
SLDB
CTRN
Price
$6.17
$47.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
2
Target Price
$18.71
★ $91.00
AVG Volume (30 Days)
★ 1.3M
143.9K
Earning Date
11-10-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
34.97
★ 112.14
EPS
N/A
★ 0.80
Revenue
$8,094,000.00
★ $819,962,000.00
Revenue This Year
N/A
$10.94
Revenue Next Year
N/A
$8.69
P/E Ratio
★ N/A
$60.35
Revenue Growth
N/A
★ 8.88
52 Week Low
$3.79
$35.00
52 Week High
$11.45
$77.91

Technical Indicators

Market Signals
Indicator
SLDB
CTRN
Relative Strength Index (RSI) 42.00 43.81
Support Level $5.38 $47.08
Resistance Level $6.77 $52.83
Average True Range (ATR) 0.46 2.30
MACD 0.12 0.50
Stochastic Oscillator 63.64 53.01

Price Performance

Historical Comparison
SLDB
CTRN

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

About CTRN Citi Trends Inc.

Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.

Share on Social Networks: